Ghost Tree Capital, LLC Biocryst Pharmaceuticals Inc Transaction History

Ghost Tree Capital, LLC

$267 Million
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$6.96 - $8.81 $522,000 - $660,750	-75,000 Reduced 27.27%	200,000 $1.41 Million
Q1 2023 May 15, 2023	BUY	$7.94 - $11.84 $397,000 - $592,000	50,000 Added 22.22%	275,000 $2.29 Million
Q4 2022 Feb 14, 2023	SELL	$10.5 - $14.2 $3.15 Million - $4.26 Million	-300,000 Reduced 57.14%	225,000 $2.58 Million
Q3 2022 Nov 14, 2022	BUY	$10.79 - $14.81 $2.16 Million - $2.96 Million	200,000 Added 61.54%	525,000 $6.62 Million
Q2 2022 Aug 15, 2022	SELL	$7.89 - $17.88 $197,250 - $447,000	-25,000 Reduced 7.14%	325,000 $3.44 Million
Q1 2022 May 16, 2022	BUY	$11.56 - $19.76 $4.05 Million - $6.92 Million	350,000 New	350,000 $5.69 Million
Q2 2021 Aug 11, 2021	SELL	$9.5 - $17.24 $4.75 Million - $8.62 Million	-500,000 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$7.37 - $13.61 $2.95 Million - $5.44 Million	-400,000 Reduced 44.44%	500,000 $5.09 Million
Q4 2020 Feb 16, 2021	SELL	$3.37 - $8.61 $3.54 Million - $9.04 Million	-1,050,000 Reduced 53.85%	900,000 $6.71 Million
Q3 2020 Nov 16, 2020	BUY	$3.43 - $5.53 $171,500 - $276,500	50,000 Added 2.63%	1,950,000 $6.7 Million
Q2 2020 Aug 14, 2020	SELL	$1.9 - $5.61 $190,000 - $561,000	-100,000 Reduced 5.0%	1,900,000 $9.05 Million
Q1 2020 May 15, 2020	SELL	$1.6 - $4.11 $1.6 Million - $4.11 Million	-1,000,000 Reduced 33.33%	2,000,000 $4 Million
Q4 2019 Feb 14, 2020	BUY	$1.59 - $3.45 $2.39 Million - $5.18 Million	1,500,000 Added 100.0%	3,000,000 $10.4 Million
Q3 2019 Nov 14, 2019	SELL	$2.5 - $3.73 $2.5 Million - $3.73 Million	-1,000,000 Reduced 40.0%	1,500,000 $4.3 Million
Q2 2019 Aug 14, 2019	BUY	$2.91 - $9.15 $5.82 Million - $18.3 Million	2,000,000 Added 400.0%	2,500,000 $9.48 Million
Q3 2018 Nov 14, 2018	BUY	$5.52 - $7.99 $2.76 Million - $4 Million	500,000 New	500,000 $3.82 Million
Q4 2017 Feb 14, 2018	SELL	$4.16 - $5.33 $2.08 Million - $2.67 Million	-500,000 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$4.1 - $5.97 $2.05 Million - $2.99 Million	500,000	500,000 $2.62 Million

Others Institutions Holding BCRX

# of Institutions

279

Shares Held

172M

Call Options Held

625K

Put Options Held

739K

Vanguard Group Inc Valley Forge, PA

20.3M
Shares

$154 Million
0.0% of portfolio
Black Rock Inc. New York, NY

20M
Shares

$152 Million
0.0% of portfolio
Avoro Capital Advisors LLC New York, NY

11.9M
Shares

$90.2 Million
1.36% of portfolio
Kynam Capital Management, LP Princeton, NJ

9.09M
Shares

$69 Million
5.66% of portfolio
State Street Corp Boston, MA

8.85M
Shares

$67.3 Million
0.0% of portfolio

View Full List

About BIOCRYST PHARMACEUTICALS INC

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $1.41B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

More about BCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ghost Tree Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ghost Tree Capital, LLC with notifications on news.

Account